Audubon Bioscience to Exhibit and Speak at the Biomarkers and Immuno US 2023
Houston, TX, Sept 7th, 2023 — Audubon Bioscience, an innovative biomedical research services provider committed to advancing the landscape of cancer treatment by providing high-quality biospecimens is honored to announce its “Bronze Sponsorship” and participation in the Biomarkers US 2023 conference. The event co-located with Immuno US 2023 is scheduled to take place from October 12th to 13th, 2023, in the beautiful city of San Diego, California.
The Biomarkers US 2023 is a gathering that connects thought leaders, industry experts, and biomedical researchers from around the world. This event offers you the opportunity to acquire a forward-thinking insight into the most recent advancements and technologies influencing biomarker research. And, with more than 65 presentations spanning two days, it also promises to give a comprehensive exploration of strategies to advance the field of immuno-oncology drug development.
Benefits of Attending
This event serves as a platform for high-level discussions, fostering collaboration among global pharmaceutical, biotechnology, and academic professionals. With an emphasis on the latest innovations in the bioscience industry, participants can expect insightful dialogues that will shape the future of healthcare and research.
Attendees will be informed and connected with presentations from key opinion leaders in biomarkers for drug discovery, translational medicine, clinical development, and diagnostics, with additional focus this year on advances in precision oncology.
The Biomarkers US 2023 also promises to engage attendees and participants with advanced panels, roundtables, and workshops including: ‘Reflection On When Biomarker Development Fails And Lessons Learnt’; ‘Improving The Therapeutic Index For Bispecific T Cell Engagers’; ‘AI, Digital Pathology & Imaging Biomarkers For Biomarker Analysis’; and many more
Our Goal at the Biomarkers US 2023
This Biomarkers US 2023 presents us the opportunity to showcase our successful contributions to the field of bioscience and cancer research to clinicians, researchers, Pharmas, and all other oncology experts.
Attendees can engage with our team of scientists at our exhibition booth to explore our company's biobanking solutions and gain valuable insights into the evolving landscape of biospecimen procurement and its role in biomarker discovery.
Our representatives Brittany Chirinos (Business Development Manager), Erik Uribe - (Client Director), and Emily Hubbard - (US Operations Director) will be available at Booth #1 to meet our partners, make new connections, discuss the latest advances in cancer biomarker discovery, and collaborate with other leaders in the field. We will also be actively participating in discussions that drive innovation in biomarker research efforts.
Audubon Bioscience invites all attendees to register for the Biomarkers US 2023 conference to experience firsthand the dynamic atmosphere of knowledge exchange and collaboration. Don't miss the opportunity to connect with Audubon Bioscience's conference team and explore the possibilities of advancing bioscience together.
About Biomarkers Series 2023
The Biomarkers Series 2023 is a set of top-notch events connecting leaders, experts, and researchers, to global pharma, biotech, and academia for high-level discussions on the latest innovations in the bioscience industry. It promises to cover topics on Biomarkers, Genomic Markers, Digital Biomarkers, CTCs & Liquid Biopsies, Flow Cytometry & Multiplex Tools, and more.
Join Audubon Bioscience at Biomarkers US 2023 in San Diego on October 12-13, 2023, and be a part of shaping the future of bioscience innovation. Schedule a meeting with our Client Director, Erik Uribe
To discover more about our commitment to medical innovation through the procurement of high-quality biospecimens for researchers and clinicians, visit our website or speak directly with our scientific experts.
